Tau brain imaging in typical and atypical Alzheimer’s Disease (AD)
Phase 1
- Conditions
- Alzheimer's diseasesTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]
- Registration Number
- EUCTR2016-002223-28-FR
- Lead Sponsor
- CHRU DE TOURS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
- Age = 50 years
- Native language: French
- Studies level = 7 years (considering as a starting point in the first year of primary education)
- Correct sensory capabilities (hearing aids accepted) to perform the tests
- Affiliation to the social security system,
- Informed Consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method